VRDN
Viridian Therapeutics Inc.
$19.60
+$0.05(+0.26%)
81
Overall
--
Value
81
Tech
--
Quality
Market Cap
$1.59B
Volume
336.64K
52W Range
$9.90 - $27.20
Target Price
$39.47
EPS Estimates Overview
| Current Quarter | $-0.72 | Next Quarter | $-1.06 |
| Current Year | $-3.77 | Next Year | $-4.07 |
| QoQ Growth | -47.2% | YoY Growth | -8.0% |
| 3Y EPS CAGR | +22.8% | Target Price | $39.47 |
| Consensus | Buy | Upside | +101.4% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRDN | $19.60 | +0.3% | 336.64K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Viridian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW